Efficacy News and Research

RSS

Broad neutralization capability of potent nanobody against SARS-CoV-2 variants

A new study has described the molecular basis of the neutralization potency and breadth of nanobodies.

16 Nov 2021

Diagnostic sensitivity, viral load and infectivity of SARS-CoV-2 in paired respiratory and oral samples

To understand the viral load in different sections of infected individuals, their respective shedding patterns, and the sensitivity of the SARS-CoV-2 assays, researchers published a study.

16 Nov 2021

Myocarditis among Moderna COVID-19 vaccine recipients

A new preprint reports on the incidence of myocarditis in a large population of over 150 million who received two doses of the first vaccine to receive emergency use authorization against the virus.

16 Nov 2021

Researchers develop a highly efficient method to generate immune cells for cancer therapies

A Ludwig Cancer Research study has devised a highly efficient method to generate large numbers of immune cells specifically engineered to recognize neoantigens - small fragments of randomly mutated proteins that are typically unique to a patient's cancer - and destroy the tumors that express them.

15 Nov 2021

Promising results from Phase II REGEN-COV study

Initial results of the REGEN-COV Phase II study are presented.

15 Nov 2021

Common hypertension drug not effective in slowing down the progression of Alzheimer's disease

New research led by the University of Bristol, has shown the drug losartan, normally used to treat high blood pressure (hypertension), is not effective in slowing down the progression of Alzheimer's disease (AD) in people with mild-to-moderate disease after 12 months of treatment.

15 Nov 2021

Three doses of COVID-19 mRNA vaccination safe in high-risk populations

A new study determines the safety of an additional vaccine among individuals who previously received two doses of mRNA-based COVID-19 vaccines.

15 Nov 2021

Mainstream media coverage of vaccines during COVID-19 pandemic

A recent study explores how vaccine coverage has come to the forefront of modern news media following the emergence of SARS-CoV-2.

15 Nov 2021

Public health strategies associated with reduced SARS-CoV-2 transmission in Switzerland

The current study attempts to estimate the quantitative effects of specific measures, using a combination of phylogenetic and phylodynamic approaches.

15 Nov 2021

Vaccination model for endemic COVID-19

The current model is meant to provide an understanding of what might happen in the future, with periods of very low infection prevalence, interspersed between surges that have ever-lower peaks.

15 Nov 2021

Type 2 diabetes medication works effectively, safely in patients hospitalized for acute heart failure

Adults treated with empagliflozin during hospitalization for acute heart failure experienced a clinical benefit such as increased survival, lower risk of heart failure hospital readmission and an overall improvement in their quality of life, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021

Partial resistance to neutralizing antibodies and enhanced transmissibility of SARS-CoV-2 Delta variant

A new study estimates the efficacy of the immune response induced by vaccination and natural COVID-19 infection against the Kappa and Delta lineages.

14 Nov 2021

Study assesses whether medicinal mushrooms and Chinese herbs can help treat COVID-19

A novel study is assessing whether medicinal mushrooms and Chinese herbs provide therapeutic benefit in treating acute COVID-19 infection.

12 Nov 2021

NanoTCE technology shows promise for treatment of acute myeloid leukemia

Oncotarget published "Nanoparticle T cell engagers for the treatment of acute myeloid leukemia" which reported that Acute myeloid leukemia (AML) is the most common type of leukemia and has a 5-year survival rate of 25%.

12 Nov 2021

Recipe to decontaminate disposable facemasks

Here's the recipe to decontaminate a disposable facemask: Heat it at 160 degrees Fahrenheit in an oven for five minutes. You can use your own oven.

12 Nov 2021

Potential therapeutic targets of hydrogen for treatment of the COVID-19

A recent article provided a review of a study led by academician Zhong Nanshan, in China, on COVID-19 treatment by inhalation of a mixed gas composed of hydrogen and oxygen.

12 Nov 2021

SARS-CoV-2 self-amplifying mRNA vaccine demonstrates cellular and humoral immune responses

Researchers from the US recently reported the preclinical development of a self-amplifying mRNA (SAM) vaccine that encodes a prefusion-stabilized SARS-CoV-2 spike glycoprotein.

12 Nov 2021

Xanthohumol as a potent pan-inhibitor for various coronaviruses

Researchers from China reported the results of their study aimed at finding an effective Mpro inhibitor since Mpro is the best drug target to fight SARS-CoV-2 infection.

12 Nov 2021

How safe is it to travel on public transport amid COVID-19?

The authors extended this research by proposing a time-varying weighted Public Transportation Encounter Network that modeled the COVID-19 infectious process observed on public transport.

12 Nov 2021

Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program

A team of scientists describe the safety and response to REGEN-COV® for COVID-19 patients with immunodeficiency-associated antibody disorders.

11 Nov 2021

Efficacy News and Research

Broad neutralization capability of potent nanobody against SARS-CoV-2 variants

Diagnostic sensitivity, viral load and infectivity of SARS-CoV-2 in paired respiratory and oral samples

Myocarditis among Moderna COVID-19 vaccine recipients

Researchers develop a highly efficient method to generate immune cells for cancer therapies

Promising results from Phase II REGEN-COV study

Common hypertension drug not effective in slowing down the progression of Alzheimer's disease

Three doses of COVID-19 mRNA vaccination safe in high-risk populations

Mainstream media coverage of vaccines during COVID-19 pandemic

Public health strategies associated with reduced SARS-CoV-2 transmission in Switzerland

Vaccination model for endemic COVID-19

Type 2 diabetes medication works effectively, safely in patients hospitalized for acute heart failure

Partial resistance to neutralizing antibodies and enhanced transmissibility of SARS-CoV-2 Delta variant

Study assesses whether medicinal mushrooms and Chinese herbs can help treat COVID-19

NanoTCE technology shows promise for treatment of acute myeloid leukemia

Recipe to decontaminate disposable facemasks

Potential therapeutic targets of hydrogen for treatment of the COVID-19

SARS-CoV-2 self-amplifying mRNA vaccine demonstrates cellular and humoral immune responses

Xanthohumol as a potent pan-inhibitor for various coronaviruses

How safe is it to travel on public transport amid COVID-19?

Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News